Literature DB >> 12617237

Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee.

J T Robertson1, B C Gunter, G W Somes.   

Abstract

This study records the incidence of glioblastoma multiforme, astrocytoma and oligodendroglioma in the white and Black patients in the Memphis Statistical Metropolitan Area (MSMA) during a 10.5-year period from 1 January 1984 through 30 June 1994. During this time, only six hospitals performed craniotomy and computer tomography (CT) scanning was routine in each of the hospitals. A total of 824 histologically confirmed first diagnoses were made at these six area hospitals. Based on the zip code listed as the home address, we determined patient's locale and identified 373 patients (232 glioblastoma multiforme, 106 astrocytomas and 35 oligodendroglioma) who resided in the area during the study interval. There were 50 black and 323 white patients. The background population for the area was obtained from the US Census Bureau's statistics for the year 1990. These statistics indicated that 40.5% of the population identified themselves as black and 57.9% as white. Age adjusted incidence rates were 1.550 (p < 0.001) for other astrocytomas, and 0.106 and 0.461 (p = 0.003) in the black and white populations, respectively. There was no significant difference in survival between the two populations. This study confirms a significant disparity in incidence rates for the three most common gliomas between the black and white populations and this disparity is higher than predicted by previous reports.

Entities:  

Mesh:

Year:  2002        PMID: 12617237

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  22 in total

1.  The survival of patients with high grade glioma from different ethnic groups in South East England.

Authors:  T Ratneswaren; R M Jack; D Tataru; E A Davies
Journal:  J Neurooncol       Date:  2014-08-26       Impact factor: 4.130

2.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

Review 3.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Authors:  Haley Gittleman; David J Cote; Quinn T Ostrom; Carol Kruchko; Timothy R Smith; Elizabeth B Claus; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

5.  Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.

Authors:  Song Tao Timothy Cheo; Gek Hsiang Lim; Keith Hsiu Chin Lim
Journal:  Singapore Med J       Date:  2016-02-26       Impact factor: 1.858

6.  Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma.

Authors:  Bin Huang; Therese A Dolecek; Quan Chen; Catherine R Garcia; Thomas Pittman; John L Villano
Journal:  Med Oncol       Date:  2018-04-17       Impact factor: 3.064

7.  Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens.

Authors:  Young Goo Kim; Soyoun Jeon; Ga-Yeong Sin; Jin-Kyoung Shim; Bo-Kyung Kim; Hye-Jin Shin; Ji-Hyun Lee; Yong-Min Huh; Su-Jae Lee; Eui-Hyun Kim; Eun Kyung Park; Se-Hoon Kim; Jong Hee Chang; Dong Seok Kim; Sun Ho Kim; Yong-Kil Hong; Seok-Gu Kang; Frederick F Lang
Journal:  Childs Nerv Syst       Date:  2012-12-29       Impact factor: 1.475

8.  Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism.

Authors:  Meijing Wu; Jason Miska; Ting Xiao; Peng Zhang; J Robert Kane; Irina V Balyasnikova; James P Chandler; Craig M Horbinski; Maciej S Lesniak
Journal:  J Neurooncol       Date:  2019-01-31       Impact factor: 4.130

Review 9.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

10.  Incidence of first primary central nervous system tumors in California, 2001-2005.

Authors:  Monica Brown; Rudolph Schrot; Katrina Bauer; Deanna Letendre
Journal:  J Neurooncol       Date:  2009-04-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.